Searched for
MOMENTA GLOBAL
Global Market: Momenta Global debuts nearly flat in Hong Kong after $751 million IPOMomenta Global shares debuted on the Hong Kong Stock Exchange with a muted reception. The autonomous-driving software developer raised HK$5...- China's Momenta kicks off Hong Kong IPO, targets up to $751 millionThe IPO comes as Chinese technology firms are returning to public markets, helped by investor demand for companies tied to AI, chips and au...
- Uber partners with China's Pony AI to deploy self-driving taxis in key Middle East marketUber is partnering with China’s Pony AI to deploy robotaxis, starting in the Middle East later this year. The move strengthens Uber’s posit...
- Oppenheimer and the business of nuclear powerThe undecidedness about nuclear energy is in stark contrast to J. Robert Oppenheimer's Bhagavad Gita-inspired equanimity about his creation...
- Paytm founder’s pre-IPO windfall; Google sues CCIIPO-bound Paytm, which recently increased its employee stock options pool from around 24 million to around 61 million, has given almost hal...
- GM invests in Chinese autonomous driving startup MomentaAutomakers and technology firms are investing billions of dollars in autonomous driving, aiming to take an early lead in what many consider...
- Culture of ‘bending rules’ in India challenges U.S. drug agencyThe US drug agency is bewildered with Indian pharma industry's culture of getting things done at all costs.
- Oncology solutions company Mitra Biotech gets $40 millionBoston and Bengaluru-based Mitra Biotech develops and provides novel technologies that personalise cancer treatment.
- Mitra Biotech raises $27.4 million in Series B funding led by Sequoia India"These new funds will allow us to enhance our technology and engage in new studies to further demonstrate CANScript’s clinical utility," sa...
- We're here to stay, open to buy right portfolio: Rajiv Malik, President, MylanMylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.
- Teva may move court against Dr Reddy's for patent infringementThe Israeli drug maker already is involved in various legal battles with other drug firms over the patent litigations of Copaxone.
- US Fed tapering will not suck big liquidity out of the world markets: Ravi Dharamshi, ValueQuest Investment'India, receives a drop in the ocean in terms of global liquidity, is not going to get funds just because there is liquidity.'
- We are very bullish on technology: Ravi Dharamshi, ValueQuest Investment Advisors"We are very bullish on technology per se. Narayana Murthy has come in and has spelt out his strategy. The strategy is to get cost under co...
- Celebrating failure paves way for greater achievement, says Kamran ElahianSerial entrepreneur Kamran Elahian has co-founded 10 firms, of which 6 were successes. But he treasures his “first and biggest” failure the...
- Natco Pharma loses patent case against Teva Pharmaceutical Industries of anti-sclerosis drugNatco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug,...
- India Innovation Fund to invest 10 crore in SureWaves Media TechIndia Innovation Fund, best known as the only domestic venture fund that is backed by software services major TCS and telecom leader Airtel...
- Indian drug cos prepare a peptide mixAs blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
Load More
